NewEdge Advisors LLC Increases Position in Alpha Teknova, Inc. (NASDAQ:TKNO)

NewEdge Advisors LLC lifted its position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO) by 14.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 15,632 shares of the company’s stock after purchasing an additional 1,953 shares during the period. NewEdge Advisors LLC’s holdings in Alpha Teknova were worth $131,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. State Street Corp raised its holdings in Alpha Teknova by 249.3% during the third quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after acquiring an additional 54,700 shares during the period. Nkcfo LLC bought a new stake in Alpha Teknova during the 4th quarter valued at approximately $501,000. Invesco Ltd. purchased a new position in Alpha Teknova in the 4th quarter worth approximately $9,236,000. Raymond James Financial Inc. bought a new position in Alpha Teknova in the 4th quarter worth approximately $716,000. Finally, Geode Capital Management LLC grew its holdings in Alpha Teknova by 24.4% during the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after buying an additional 36,914 shares in the last quarter. Institutional investors own 13.81% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Craig Hallum started coverage on shares of Alpha Teknova in a report on Monday, February 10th. They issued a “buy” rating and a $12.00 target price on the stock.

Alpha Teknova Trading Down 1.4 %

Shares of TKNO stock opened at $6.52 on Friday. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $348.41 million, a price-to-earnings ratio of -8.81 and a beta of 0.54. Alpha Teknova, Inc. has a 12-month low of $1.16 and a 12-month high of $10.37. The stock’s 50-day moving average price is $5.77 and its 200-day moving average price is $7.11.

Alpha Teknova (NASDAQ:TKNO) last released its quarterly earnings data on Tuesday, March 4th. The company reported ($0.11) earnings per share (EPS) for the quarter. The firm had revenue of $9.27 million during the quarter, compared to the consensus estimate of $9.10 million. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. Equities research analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.